Sotrovimab
215226
Phase 2 mab terminated
Quick answer
Sotrovimab for COVID-19 is a Phase 2 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated